76
Views
4
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer

, , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qianying Zhu, Lushan Yu, Zhiyuan Qin, Lu Chen, Haihong Hu, Xiaoli Zheng & Su Zeng. (2019) Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma. Epigenetics 14:8, pages 791-803.
Read now

Articles from other publishers (3)

Pratik Patil, VineetGovinda Gupta, RangaRao Rangaraju, Waseem Abbas, RudraPrasad Acharya & Archit Pandit. (2020) Survival outcomes with docetaxel, oxaliplatin, and fluorouracil regimen for the treatment of metastatic gastric adenocarcinoma: A single-center experience. Oncology Journal of India 4:3, pages 110.
Crossref
Roberto Petrioli, Giandomenico Roviello, Laura Zanotti, Franco Roviello, Karol Polom, Alberto Bottini, Luigi Marano, Edoardo Francini, Daniele Marrelli & Daniele Generali. (2016) Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 102, pages 82-88.
Crossref
Junxun Ma, Sheng Yao, Xiao-Song Li, Huan-Rong Kang, Fang-Fang Yao & Nan Du. (2015) Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer. Medicine 94:42, pages e1489.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.